Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent is trading on deal odds now, not on drug data. Shares last traded at $123.25, up 39.28%, after GSK said it will buy the Nasdaq-listed biotech for $124 per share in cash. That leaves just a small discount to the offer price. Nuvalent’s stock is being valued more like a GSK takeover play than an oncology bet.

Mergers and Acquisitions · NASDAQ:NUVL · NYSE:GSK · Pharmaceuticals · Stock Market
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

Dow, S&P 500 edge up, Nasdaq slips in midday trade U.S. stocks were mixed late Tuesday morning. The Dow and S&P 500 held small gains, while the Nasdaq slipped after a rebound in artificial-intelligence shares and ahead of another inflation readout this week. Delayed LSEG data from Reuters showed the S&P 500 up 0.22% at 7,421.81, the Dow up 0.30% at 50,940.88, and the Nasdaq down 0.03% at 25,921.29.
9 June 2026
·········
Follow on Google News
Add as preferred source Open in Google News

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong buy

Alphabet

NASDAQ:GOOGL 92/100 • ★★★★½
#2 Strong buy

Taiwan Semiconductor Manufacturing

NYSE:TSM 89/100 • ★★★★½
#3 Buy

S&P Global

NYSE:SPGI 88/100 • ★★★★
#4 Buy on weakness

Amazon

NASDAQ:AMZN 86/100 • ★★★★
#5 Buy on weakness

Microsoft

NASDAQ:MSFT 84/100 • ★★★★
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

U.S. index futures reopen at 18:00 ET

This is the clearest scheduled U.S.-market price-discovery point today and can transmit weekend news into equity-index futures before Monday's cash session.

#2

New Zealand retail sales at 18:45 ET

The Q2 retail package can move NZD and regional risk sentiment. Spillover to U.S. assets is usually secondary unless the result is unusually large.

#3

No scheduled domestic U.S. data or corporate reports

The absence of U.S. releases, earnings, IPO pricings and split events leaves fewer scheduled catalysts, increasing the relative importance of weekend headlines and positioning at the futures reopen.

View full calendar
Times and estimates may change. Verify before trading.